TAM‐Derived Exosomes Promote EMT by Upregulating lncRNA MIR4435‐2HG in Head and Neck Cancer

ABSTRACT Objective This study aimed to investigate the impact of tumor‐associated macrophage (TAM)‐derived exosomes on epithelial–mesenchymal transition (EMT) in head and neck squamous cell carcinoma (HNSCC) and the underlying mechanisms involved. Subjects and Methods Exosomes were isolated and char...

Full description

Saved in:
Bibliographic Details
Published inOral diseases Vol. 31; no. 4; pp. 1154 - 1164
Main Authors Liu, Junjiang, Mu, Jingtian, Liang, Zhi, Zhang, Yizhi, Hu, Tao, Wu, Fanglong, Zhou, Hongmei
Format Journal Article
LanguageEnglish
Published Denmark Wiley Subscription Services, Inc 01.04.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Objective This study aimed to investigate the impact of tumor‐associated macrophage (TAM)‐derived exosomes on epithelial–mesenchymal transition (EMT) in head and neck squamous cell carcinoma (HNSCC) and the underlying mechanisms involved. Subjects and Methods Exosomes were isolated and characterized using transmission electron microscopy, nanoparticle size analysis, and western blotting. The effect on EMT in HNSCC cells was assessed using wound healing, transwell invasion, and EMT marker assays. Bioinformatics analysis was conducted to predict key TAM‐related long noncoding RNAs and evaluate their relationship with EMT in HNSCC. Results We observed that treatment with TAM‐derived conditioned medium (CM) promoted EMT in HNSCC cells. Within the CM, we observed abundant exosomes that were taken up by HNSCC cells. Furthermore, TAM‐derived exosomes promoted EMT in HNSCC cells. Mechanistically, high MIR4435‐2HG expression levels were observed in TAM‐derived exosomes and in HNSCC cells after treatment with TAM‐derived exosomes. Notably, high MIR4435‐2HG expression levels may be closely related to molecules that promote EMT in HNSCC. Conclusions TAM‐derived exosomes promote EMT in HNSCC cells by upregulating MIR4435‐2HG expression, suggesting that MIR4435‐2HG is a candidate target for HNSCC therapy.
Bibliography:Funding
This work was supported by National Natural Science Foundation of China (Nos. 82370963, 82071124, and U20A20365) and the Sichuan Science and Technology Program (Nos. 2023ZYD0104, 2023NSFSC0552, and 2024YFFK0373).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1354-523X
1601-0825
1601-0825
DOI:10.1111/odi.15212